|Issuer:||RXSIGHT, INC. (RXST)|
|Original Submission Date:|
C/O RXSIGHT, INC.
100 COLUMBIA ALISO VIEJO, CA 92656
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|f1||each restricted stock unit ("rsu") represents a contingent right to receive one share of rxsight, inc. common stock.|
|f2||subject to the reporting person's continuing as an outside director (as defined in the issuer's 2021 equity incentive plan) through such applicable vesting date, one hundred percent (100%) of the rsus subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the date of grant or (ii) the date immediately prior to the next annual meeting of stockholders following the date of grant. "date of grant" shall mean june 2, 2022.|